% alzhub.org library filter
% Source: https://alzhub.org/research?author=Blankenstein+MA&access=free
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{galimberti2006-16606766,
  author  = {Galimberti, D. and Schoonenboom, N. and Scheltens, P. and Fenoglio, C. and Bouwman, F. and Venturelli, E. and Guidi, I. and Blankenstein, M. A. and others},
  title   = {{Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2006},
  doi     = {10.1001/archneur.63.4.538},
  pmid    = {16606766},
  url     = {https://doi.org/10.1001/archneur.63.4.538}
}

@article{schoonenboom2012-22170879,
  author  = {Schoonenboom, N. S. and Reesink, F. E. and Verwey, N. A. and Kester, M. I. and Teunissen, C. E. and van de Ven, P. M. and Pijnenburg, Y. A. and Blankenstein, M. A. and others},
  title   = {{Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e31823ed0f0},
  pmid    = {22170879},
  url     = {https://doi.org/10.1212/wnl.0b013e31823ed0f0}
}

@article{mulder2010-19833838,
  author  = {Mulder, C. and Verwey, N. A. and van der Flier, W. M. and Bouwman, F. H. and Kok, A. and van Elk, E. J. and Scheltens, P. and Blankenstein, M. A.},
  title   = {{Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease}},
  journal = {Clinical chemistry},
  year    = {2010},
  doi     = {10.1373/clinchem.2009.130518},
  pmid    = {19833838},
  url     = {https://doi.org/10.1373/clinchem.2009.130518}
}

@article{vanharten2013-23232269,
  author  = {van Harten, A. C. and Visser, P. J. and Pijnenburg, Y. A. and Teunissen, C. E. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.08.004},
  pmid    = {23232269},
  url     = {https://doi.org/10.1016/j.jalz.2012.08.004}
}

@article{henneman2009-19770469,
  author  = {Henneman, W. J. and Vrenken, H. and Barnes, J. and Sluimer, I. C. and Verwey, N. A. and Blankenstein, M. A. and Klein, M. and Fox, N. C. and others},
  title   = {{Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181b879ac},
  pmid    = {19770469},
  url     = {https://doi.org/10.1212/wnl.0b013e3181b879ac}
}

@article{goos2009-19762705,
  author  = {Goos, J. D. and Kester, M. I. and Barkhof, F. and Klein, M. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition}},
  journal = {Stroke},
  year    = {2009},
  doi     = {10.1161/strokeaha.109.558197},
  pmid    = {19762705},
  url     = {https://doi.org/10.1161/strokeaha.109.558197}
}

@article{tolboom2009-19690025,
  author  = {Tolboom, N. and van der Flier, W. M. and Yaqub, M. and Boellaard, R. and Verwey, N. A. and Blankenstein, M. A. and Windhorst, A. D. and Scheltens, P. and others},
  title   = {{Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2009},
  doi     = {10.2967/jnumed.109.064360},
  pmid    = {19690025},
  url     = {https://doi.org/10.2967/jnumed.109.064360}
}